REAL-WORLD EVIDENCE RECOMMENDATIONS FOR GENE THERAPIES: REGULATORY VERSUS HEALTH TECHNOLOGY ASSESSMENT

被引：0
|
作者：
Allen, G. [1 ]
Summers, D. M. [1 ]
Evans, J. [1 ]
机构：
[1] Costello Med, Cambridge, England
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PBI43
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [21] WHAT'S THE REALITY OF REAL-WORLD EVIDENCE IN HEALTH TECHNOLOGY APPRAISAL?
    Sarni, G.
    Lambrelli, D.
    Gulea, C.
    GomezEspinosa, E.
    Iheanacho, I.
    VALUE IN HEALTH, 2017, 20 (09) : A773 - A773
  • [22] REAL-WORLD EVIDENCE (RWE) TO SUPPORT REGULATORY SUBMISSIONS: LANDSCAPE ASSESSMENT & REVIEW
    Haris, G.
    Acha, V
    Liu, S.
    Burcu, M.
    VALUE IN HEALTH, 2023, 26 (06) : S213 - S213
  • [23] Regulatory and health technology assessment of cell and gene therapies in Europe: Convergence or divergence?
    Hoogendoorn, Mark
    Fabriek, Babs
    Bloem, Lourens T.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 16 - 16
  • [24] The maze of real-world evidence frameworks: from a desert to a jungle! An environmental scan and comparison acro ss regulatory and health technology assessment agencies
    Sarri, Grammati
    Hernandez, Luis G.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024, 13 (09)
  • [25] Multiple Perspectives on the Need for Real-World Evidence to Inform Regulatory and Health Technology Assessment Decision-Making: Scoping Review and Stakeholder Interviews
    Jansen, Marieke S.
    Dekkers, Olaf M.
    le Cessie, Saskia
    Hooft, Lotty
    Gardarsdottir, Helga
    de Boer, Anthonius
    Groenwold, Rolf H. H.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2025, 34 (01)
  • [26] Real-world evidence in health technology assessment of high-risk medical devices: Fit for purpose?
    Klein, Philip
    Blommestein, Hedwig
    Al, Maiwenn
    Pongiglione, Benedetta
    Torbica, Aleksandra
    de Groot, Saskia
    HEALTH ECONOMICS, 2022, 31 : 10 - 24
  • [27] Real-world evidence in lung and hematologic oncology health technology appraisals: a review of six assessment agencies
    Harricharan, Sharada
    Curran, Eileen
    Lin, Huamao Mark
    Walton, Laura
    Gurjar, Khushboo
    Nguyen, Khoi
    Forsythe, Anna
    FUTURE ONCOLOGY, 2023, : 603 - 616
  • [28] Applicability of Appraisal Tools of Real-World Evidence in Health Technology Assessment: A Literature Review and Content Analysis
    Jiu, L.
    Hartog, M. K.
    Wang, J.
    Vreman, R. A.
    Mantel-Teeuwisse, A. K.
    Goettsch, W. G.
    VALUE IN HEALTH, 2022, 25 (12) : S389 - S389
  • [29] A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada
    Regier, Dean A.
    Pollard, Samantha
    McPhail, Melanie
    Bubela, Tania
    Hanna, Timothy P.
    Ho, Cheryl
    Lim, Howard J.
    Chan, Kelvin
    Peacock, Stuart J.
    Weymann, Deirdre
    NPJ PRECISION ONCOLOGY, 2022, 6 (01)
  • [30] A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada
    Dean A. Regier
    Samantha Pollard
    Melanie McPhail
    Tania Bubela
    Timothy P. Hanna
    Cheryl Ho
    Howard J. Lim
    Kelvin Chan
    Stuart J. Peacock
    Deirdre Weymann
    npj Precision Oncology, 6
12345